论文部分内容阅读
高脂血症是由于体内脂质代谢紊乱而形成的一种病症，是导致动脉粥样硬化、冠心病、高血压、脑卒中的独立危险因素。随着人们生活水平提高和生活方式改变，该病有逐渐增高趋势。笔者应用自拟降脂通脉合剂治疗高脂血症与用辛伐他汀治疗３２例（以下简称对照组）比较研究，旨在了
Hyperlipidemia is a disorder caused by disorder of lipid metabolism in vivo and is an independent risk factor for atherosclerosis, coronary heart disease, hypertension and stroke. With the improvement of people’s living standards and lifestyle changes, the disease tends to increase gradually. The author applied self-made lipid-lowering Tongmai mixture treatment of hyperlipidemia and simvastatin treatment of 32 cases (hereinafter referred to as the control group) comparative study, aimed at